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Molecular typing analysis 
showed that both case-patients had 
a monoclonal infection caused by C. 
diffi cile ribotype 027. Both isolates 
had tcdA, tcdB, and cdtB and had a 
deletion in tcdC (data not shown).
In summary, the described severe 
cases of C. diffi cile infection in Chile 
were caused by epidemic C. diffi cile 
ribotype 027. One of these case-
patients required urgent colectomy. 
These results demonstrate that 
epidemic C. diffi cile 027 strains are 
present in South America, highlighting 
the need for enhanced screening for 
this ribotype in other regions of the 
continent.
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Zoo notic Pathogens 
among White-Tailed 
Deer, Northern 
Mexico, 2004–2009
To the Editor: Intense wildlife 
management for hunting affects risks 
associated with zoonotic pathogens 
(1). White-tailed deer (Odocoileus 
virginianus) are increasingly managed 
by fencing, feeding, watering, and 
translocation to increase incomes 
from hunting in northern Mexico (2). 
These deer also play a major role in 
dissemination and reintroduction of 
pathogens and vectors from Mexico 
into the United States (3,4). White-
tailed deer are suitable reservoir hosts 
for Mycobacterium bovis (1), and an 
M. bovis-positive white-tailed deer 
was recently found in Tamaulipas in 
northeastern Mexico (2). Brucellosis 
is widespread in many animal hosts 
in Latin America (5) and thus of 
interest in white-tailed deer. Another 
major zoonosis, sometimes linked 
to raw deer meat consumption, 
is hepatitis E, which is caused by 
genotypes of hepatitis E virus (HEV) 
(6). HEV is increasingly prevalent 
in red deer (Cervus elaphus) (7), but 
its prevalence in white-tailed deer is 
unknown.
The objective of this study was to 
determine the prevalence of zoonotic 
pathogens in white-tailed deer in 
northern Mexico. This study was 
conducted under a scientifi c collecting 
permit issued by the Mexican Division 
of Animal and Wildlife Health and 
on 8 ranches in 3 states in northern 
Mexico (≈26–28°N, 99–100°W). 
Serum samples (n = 347) 
were collected during 2004–2009 
in a cross-sectional survey for 
antibodies against HEV, Brucella 
spp., and mycobacteria.  Deer were 
opportunistically sampled during 
live-capture operations as described 
by Cantú et al. (8). Bleeding 
was performed by using jugular 
venipuncture and vacuum tubes 
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without anticoagulant. Samples 
were allowed to clot and centrifuged 
to collect serum that was stored at 
−20°C.
Serum samples were tested 
for IgG against HEV by ELISA as 
described (7). Serum samples were 
also tested for antibodies against 
Brucella spp. by using a commercial 
ELISA (Ingezim Brucella Compac 
2.0 Ingenasa, Madrid, Spain), 
according to the manufacturer’s 
instructions. Detection of antibodies 
cross-reacting with 2 widely used 
mycobacterial antigens, bovine 
purifi ed protein derivative (PPD) 
and paratuberculosis protoplasmatic 
antigen 3 (PPA3), was conducted as 
described (9). The sensitivity and 
specifi city of this assay have not been 
established for white-tailed deer, but 
it has been used in seroprevalence 
studies of wild boar and fallow deer 
(9,10).
Insuffi cient volumes of serum 
samples prevented testing for 
antibodies against all pathogens 
(Table). Limited serum volume and 
lack of other (organ) samples also 
precluded additional analyses to verify 
presence of pathogens.
Prevalence was 62.7% (95% CI 
54%–70%) for antibodies against 
HEV, 0.4% (95% CI 0%–2%) for 
antibodies against Brucella spp., 8.9% 
(95% CI 6%–13%) for antibodies 
against bovine PPD, and 2.6% (95% 
CI 1%–5%) for antibodies against 
PPA3 (Table). Antibody responses 
to bovine PPD were detected in deer 
from at 6 of 8 sampling sites; in deer 
from 3 of these sites, antibodies were 
also detected against PPA3 antigen. 
Seroprevalence against bovine PPD 
was higher than that against PPA3 (χ2 
10.9, df 1, p<0.01).
This cross-sectional survey 
of white-tailed deer in northern 
Mexico detected antibodies to 
several pathogens relevant to public 
and animal health. High prevalence 
of antibodies against HEV and 
frequent detection of antibodies 
against mycobacterial antigens are 
public health concerns. Prevalence 
of antibodies against HEV were 3× 
higher than that reported for red deer 
in Europe (7). This result suggests 
wide circulation of HEV in the study 
region and warrants further research, 
including detection and sequencing 
of virus RNA. Low Brucella spp. 
antibody prevalence confi rms results 
of a study in this region (8).
Antibody responses to bovine 
PPD were detected in serum samples 
from deer from most sampling 
sites, occasionally in the absence 
of antibodies against PPA3. These 
results, and a recent report of an M. 
bovis–positive white-tailed deer from 
this region (2), suggest that these 
deer may be contracting M. bovis in 
northern Mexico. If one considers 
that white-tailed deer are M. bovis 
reservoirs in other parts of North 
America and that risk factors such 
as supplemental feeding are present 
in northern Mexico, there is a high 
risk for pathogen transmission to 
animals and humans (1). White-tailed 
deer are probably exposed to several 
pathogens that are relevant to animal 
health in northern Mexico.
Although this cross-sectional 
survey provided only an indication 
of pathogen prevalence in the study 
populations, high antibody prevalence 
to HEV and mycobacterial antigens 
requires antigen-targeted surveillance. 
Risks associated with pathogen 
translocation by white-tailed deer are 
also relevant to neighboring states in 
Mexico and the United States.
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Table. Prevalence of serum antibodies against zoonotic pathogen antigens among white-tailed deer on 8 ranches, northern Mexico,
2004–2009* 
Ranch no. State Municipality Sample size 
No. positive/no. tested (%) 
HEV Brucella spp. Bovine PPD PPA3 
1 Tamaulipas Guerrero 1 0/1 (0) 0/1 (0) 0/1 (0) 0/1 (0) 
2 Tamaulipas Guerrero 106 41/71 (57.7) 0/102 (0) 9/102 (8.8) 0/102 (0) 
3 Tamaulipas Nuevo Laredo 37 21/27 (77.7) 0 0/37 (0) 0/37 (0) 
4 Nuevo León Unknown 35 0 0 3/35 (8.5) 2/35 (5.7) 
5 Coahuila Guerrero 35 1/1 (100) 0/33 (0) 2/33 (6.0) 1/33 (3.0) 
6 Coahuila Guerrero 50 6/17 (35.2) 0/40 (0) 3/40 (7.5) 0/40 (0) 
7 Coahuila Hidalgo 17 4/6 (66.6) 1/16 (6.2) 3/16 (18.7) 5/16 (31.2) 
8 Coahuila Guerrero 66 16/19 (84.2) 0/39 (0) 7/39 (18.0) 0/39 (0) 
NA Total NA 347 89/142 (62.7) 1/231 (0.4) 27/303 (8.9) 8/303 (2.6) 
*HEV, hepatitis E virus; PPD, purified protein derivative; PPA3, paratuberculosis protoplasmatic antigen 3; NA, not applicable.
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KIs Virus and Blood 
Donors, France
To the Editor: KIs-V is a new 
putative virus identifi ed recently in 
the blood of persons in Japan (1). 
First partial sequence of KIs-V was 
characterized unexpectedly, when 
PCR primers were used that were 
directed primarily to the consensus 
domain of helicase of positive-
stranded RNA viruses. Extensive 
physicochemical and molecular 
analysis suggested that KIs-V is 
an enveloped virus with a circular, 
double-stranded DNA genome of 
≈9,500 bp (prototype isolate: GenBank 
accession no. AB550431); its genetic 
diversity is presumed to be extremely 
low because the 4 complete genomes 
already characterized in Japan harbor 
strict identical sequences. The 13 
potential genes identifi ed by in 
silico analysis exhibit an overall low 
sequence homology to other known 
viral proteins (1). Until now, KIs-V 
epidemiologic data have been related 
only to the original study in which the 
authors analyzed plasma samples from 
516 blood donors categorized into 4 
groups by alanine aminotransferase 
(ALT) level (either <60 IU/L or >60 
IU/L) and the presence or absence of 
hepatitis E virus (HEV) antibodies. As 
a result, KIs-V DNA was detectable at 
elevated prevalence in the high ALT 
level/HEV antibody–positive group 
(36%, n = 100); viral loads, checked 
for a few samples, ranged from 106 to 
108 copies/mL. KIs-V DNA also was 
identifi ed in HEV antibody–negative 
samples, with low or high ALT level 
(≈0.8%, n = 120, and 1%, n = 100, 
respectively) (1).
To gain insights about the 
potential presence of this virus in 
the blood of persons in France, we 
investigated KIs-V DNA in the plasma 
of 576 healthy blood donors (mean 
age 40 years; 306 men; men:women 
1:1.13). Blood samples were collected 
in vacuum tubes (Vacutainer, SST, 
Becton Dickinson, Meylan, France) 
and centrifuged, and plasma aliquots 
were stored at −80°C until use. Nucleic 
acids were extracted from 1-mL plasma 
volumes (MagNA Pure LC, Roche 
Diagnostics, Meylan, France) (2) and 
tested for KIs-V DNA by using the 
same nested PCR system for screening 
Japanese blood donors (1). Briefl y, 
one tenth (5 μL) of extracted nucleic 
acids were fi rst amplifi ed by using 
primers 101-C (5′-CAACACCGCA
ATCACAAAGT-3′) and N101-B 
(5 ′-AACATTGAAACGTCATGT
CC-3′) (0.8 μM each) in a 50-μL 
mix containing deoxynucleotide 
triphosphates (0.2 mM each) (Roche) 
and 2 U Taq DNA polymerase 
(Invitrogen, Cergy Pontoise, France) 
with its corresponding buffer. One 
microliter of the amplifi cation mixture 
was subsequently used in a second-
round PCR with primers KS-2 
(5 ′ -CTCGTCCTCGTCGTCATC
GTA-3′) and N101-D (5′-CA
TTTGCTCCCGCTGGAGATG-
3′) under the same conditions as above. 
The amplifi cation conditions for fi rst- 
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